Corresponding Author: Karina W. Davidson, PhD, MASc, Feinstein Institutes for Medical Research, 130 E 59th St, Ste 14C, New York, NY 10032 (chair@uspstf.net).
Accepted for Publication: July 1, 2021.
Correction: This article was corrected on October 5, 2021, to fix an incorrect value in the last row of Table 2.
The US Preventive Services Task Force (USPSTF) members: Karina W. Davidson, PhD, MASc; Michael J. Barry, MD; Carol M. Mangione, MD, MSPH; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; James Stevermer, MD, MSPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York (Davidson); Harvard Medical School, Boston, Massachusetts (Barry); University of California, Los Angeles (Mangione); Albert Einstein College of Medicine, New York, New York (Cabana); Oregon Health & Science University, Portland (Caughey); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); University of Missouri, Columbia (Stevermer); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Davidson had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Justin Mills, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
3.Metzger
BE , Lowe
LP , Dyer
AR ,
et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes.
N Engl J Med. 2008;358(19):1991-2002. doi:
10.1056/NEJMoa0707943PubMedGoogle Scholar 5.DeSisto
CL , Kim
SY , Sharma
AJ . Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010.
Prev Chronic Dis. 2014;11:E104. doi:
10.5888/pcd11.130415PubMedGoogle Scholar 7.Zhou
T , Sun
D , Li
X ,
et al. Prevalence and trends in gestational diabetes mellitus among women in the United States, 2006-2016.
Diabetes. 2018;67(suppl 1):121-OR. doi:
10.2337/db18-121-ORGoogle Scholar 8.Brown
FM , Wyckoff
J . Application of one-step IADPSG versus two-step diagnostic criteria for gestational diabetes in the real world: impact on health services, clinical care, and outcomes.
Curr Diab Rep. 2017;17(10):85. doi:
10.1007/s11892-017-0922-zPubMedGoogle ScholarCrossref 9.Hartling
L , Dryden
DM , Guthrie
A ,
et al. Screening and diagnosing gestational diabetes mellitus.
Evid Rep Technol Assess (Full Rep). 2012;(210):1-327.
PubMedGoogle Scholar 10.Hartling
L , Dryden
DM , Guthrie
A , Muise
M , Vandermeer
B , Donovan
L . Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review.
Diabet Med. 2014;31(3):319-331. doi:
10.1111/dme.12357PubMedGoogle ScholarCrossref 11.Farrar
D , Simmonds
M , Bryant
M ,
et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis.
BMJ. 2016;354:i4694. doi:
10.1136/bmj.i4694PubMedGoogle Scholar 12.Lowe
WL
Jr , Scholtens
DM , Lowe
LP ,
et al; HAPO Follow-up Study Cooperative Research Group. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity.
JAMA. 2018;320(10):1005-1016. doi:
10.1001/jama.2018.11628PubMedGoogle ScholarCrossref 13.Savitz
DA , Danilack
VA , Elston
B , Lipkind
HS . Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery.
Am J Epidemiol. 2014;180(1):41-44. doi:
10.1093/aje/kwu118PubMedGoogle ScholarCrossref 16.Lowe
WL
Jr , Scholtens
DM , Kuang
A ,
et al; HAPO Follow-up Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism.
Diabetes Care. 2019;42(3):372-380. doi:
10.2337/dc18-1646PubMedGoogle ScholarCrossref 19.Deputy
NP , Kim
SY , Conrey
EJ , Bullard
KM . Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth—United States, 2012-2016.
MMWR Morb Mortal Wkly Rep. 2018;67(43):1201-1207. doi:
10.15585/mmwr.mm6743a2PubMedGoogle ScholarCrossref 24.Hedderson
M , Ehrlich
S , Sridhar
S , Darbinian
J , Moore
S , Ferrara
A . Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI.
Diabetes Care. 2012;35(7):1492-1498. doi:
10.2337/dc11-2267PubMedGoogle ScholarCrossref 25.Kim
SY , Saraiva
C , Curtis
M , Wilson
HG , Troyan
J , Sharma
AJ . Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009.
Am J Public Health. 2013;103(10):e65-e72. doi:
10.2105/AJPH.2013.301469PubMedGoogle ScholarCrossref 26.Bimson
BE , Rosenn
BM , Morris
SA , Sasso
EB , Schwartz
RA , Brustman
LE . Current trends in the diagnosis and management of gestational diabetes mellitus in the United States.
J Matern Fetal Neonatal Med. 2017;30(21):2607-2612. doi:
10.1080/14767058.2016.1257603PubMedGoogle ScholarCrossref 28.Metzger
BE , Gabbe
SG , Persson
B ,
et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.
Diabetes Care. 2010;33(3):676-682. doi:
10.2337/dc09-1848PubMedGoogle Scholar 29.Pillay
J , Donovan
L , Guitard
S ,
et al. Screening for Gestational Diabetes Mellitus: A Systematic Review to Update the 2014 U.S. Preventive Services Task Force Recommendation. Evidence Review No. 204. Agency for Healthcare Research and Quality; 2021. AHRQ publication 21-05273-EF-1.
30.Siu
AL ; US Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2015;163(11):861-868. doi:
10.7326/M15-2345PubMedGoogle ScholarCrossref 31.Curry
SJ , Krist
AH , Owens
DK ,
et al; US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement.
JAMA. 2018;320(11):1163-1171. doi:
10.1001/jama.2018.13022PubMedGoogle Scholar 32.Davidson
KW , Barry
MJ , Mangione
CM ,
et al; US Preventive Services Task Force. Behavioral counseling interventions for healthy weight and weight gain in pregnancy: US Preventive Services Task Force recommendation statement.
JAMA. 2021;325(20):2087-2093. doi:
10.1001/jama.2021.6949PubMedGoogle Scholar 33.Moyer
VA ; US Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;160(6):414-420. doi:
10.7326/M13-2905PubMedGoogle ScholarCrossref 34.Pillay
J , Donovan
L , Guitard
S ,
et al. Screening for gestational diabetes: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA. Published August 10, 2021. doi:
10.1001/jama.2021.10404Google Scholar 36.National Diabetes Data Group. Diabetes in America. 2nd ed. National Institutes of Health; 1995.
37.Crowther
CA , Hiller
JE , Moss
JR , McPhee
AJ , Jeffries
WS , Robinson
JS ; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
N Engl J Med. 2005;352(24):2477-2486. doi:
10.1056/NEJMoa042973PubMedGoogle ScholarCrossref 38.Yang
X , Tian
H , Zhang
F ,
et al. A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes.
J Transl Med. 2014;12:290. Published correction appears in
J Transl Med. 2015;13:70. doi:
10.1186/s12967-014-0290-2PubMedGoogle ScholarCrossref 39.Vandorsten
JP , Dodson
WC , Espeland
MA ,
et al. NIH consensus development conference: diagnosing gestational diabetes mellitus.
NIH Consens State Sci Statements. 2013;29(1):1-31.
PubMedGoogle Scholar